Journal of Surgical Research
Volume 157, Issue 1 , Pages e31-e37 , November 2009

AP-1 Inhibits Expression of MMP-2/9 and Its Effects on Rat Smooth Muscle Cells

  • Hong-Wei Zhang, Ph.D.

      Affiliations

    • Veteran Carder Clinic, the First Affiliated Hospital, China Medical University, Liaoning, China
  • ,
  • Xin Wang, Ph.D.

      Affiliations

    • Veteran Carder Clinic, the First Affiliated Hospital, China Medical University, Liaoning, China
  • ,
  • Zhi-Hong Zong, Ph.D.

      Affiliations

    • Department of Biochemistry, China Medical University, Liaoning, China
  • ,
  • Xin Huo, Ph.D.

      Affiliations

    • Veteran Carder Clinic, the First Affiliated Hospital, China Medical University, Liaoning, China
  • ,
  • Qiang Zhang, Ph.D.

      Affiliations

    • Veteran Carder Clinic, the First Affiliated Hospital, China Medical University, Liaoning, China
    • Corresponding Author InformationTo whom correspondence and reprint requests should be addressed at Veteran Carder Clinic, The First Affiliated Hospital, China Medical University, Shenyang 110001, Liaoning, China.

Received 5 December 2008

References 

  1. Davies MJ, Richardson PD, Woolf N, et al. Risk of thrombosis in human atherosclerotic plaques: Role of extracellular lipid, macrophage, and smooth muscle cell content. Br Heart J. 1993;69:377
  2. Sasaguri Y, Murahashi N, Sugama K, et al. Development-related changes in matrix metalloproteinase expression in human aortic smooth muscle cells. Lab Invest. 1994;71:261
  3. Sternlicht MD, Werb Z. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol. 2001;17:463
  4. Brilla CG, Zhou G, Rupp H, et al. Role of angiotensin II and prostaglandin E2 in regulating cardiac fibroblast collagen turnover. Am J Cardiol. 1995;76:8D
  5. Chase AJ, Newby AC. Regulation of matrix metalloproteinase (matrixin) genes in blood vessels: A multi-step recruitment model for pathological remodeling. J Vasc Res. 2003;40:329
  6. Mason DP, Kenagy RD, Hasenstab D, et al. Matrix metalloproteinase-9 overexpression enhances vascular smooth muscle cell migration and alters remodeling in the injured rat carotid artery. Circ Res. 1999;85:1179
  7. Carrell TW, Burnand KG, Wells GM, et al. Stromelysin-1 (matrix metalloproteinase-3) and tissue inhibitor of metalloproteinase-3 are overexpressed in the wall of abdominal aortic aneurysms. Circulation. 2002;105:477
  8. Pasterkamp G, Schoneveld AH, Hijnen DJ, et al. Atherosclerotic arterial remodeling and the localization of macrophages and matrix metalloproteases 1, 2, and 9 in the human coronary artery. Atherosclerosis. 2000;150:245
  9. Galis ZS, Khatri JJ. Matrix metalloproteinases in vascular remodeling and atherogenesis: The good, the bad, and the ugly. Circ Res. 2002;90:251
  10. Karin M, Yang-Yen HF, Chambard JC, et al. Various modes of gene regulation by nuclear receptors for steroid and thyroid hormones. Eur J Clin Pharmacol. 1993;45(Suppl 1):S9; discussion S43
  11. Porter KE, Naik J, Turner NA, et al. Simvastatin inhibits human saphenous vein neointima formation via inhibition of smooth muscle cell proliferation and migration. J Vasc Surg. 2002;36:150
  12. Benbow U, Brinckerhoff CE. The AP-1 site and MMP gene regulation: What is all the fuss about?. Matrix Biol. 1997;15:519
  13. Southgate KM, Fisher M, Banning AP, et al. Upregulation of basement membrane-degrading metalloproteinase secretion after balloon injury of pig carotid arteries. Circ Res. 1996;79:1177
  14. Turner NA, Hall KT, Ball SG, et al. Selective gene silencing of either MMP-2 or MMP-9 inhibits invasion of human saphenous vein smooth muscle cells. Atherosclerosis. 2007;193:36
  15. Fabunmi RP, Baker AH, Murray EJ, et al. Divergent regulation by growth factors and cytokines of 95 kDa and 72 kDa gelatinases and tissue inhibitors or metalloproteinases-1, -2, and -3 in rabbit aortic smooth muscle cells. Biochem J. 1996;315(Pt 1):335
  16. Stetler-Stevenson WG, Aznavoorian S, Liotta LA. Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu Rev Cell Biol. 1996;9:541
  17. Fang J, Shing Y, Wiederschain D, et al. Matrix metalloproteinase-2 is required for the switch to the angiogenic phenotype in a tumor model. Proc Natl Acad Sci U S A. 2000;97:3884
  18. Kopp CW, Holzenbein T, Steiner S, et al. Inhibition of restenosis by tissue factor pathway inhibitor: in vitro and in vitro evidence for suppressed monocyte chemoattraction and reduced gelatinolytic activity. Blood. 2004;103:1653
  19. Yamamoto S, Hijiya N, Setoguchi M, et al. Structure of the osteopontin gene and its promoter. Ann N Y Acad Sci. 1995;760:44
  20. Ahn JD, Morishita R, Kaneda Y, et al. Transcription factor decoy for activator protein-1 (AP-1) inhibits high glucose- and angiotensin II-induced type 1 plasminogen activator inhibitor (PAI-1) gene expression in cultured human vascular smooth muscle cells. Diabetologia. 2001;44:713
  21. Chen PN, Hsieh YS, Chiou HL, et al. Silibinin inhibits cell invasion through inactivation of both PI3K-Akt and MAPK signaling pathways. Chem Biol Interact. 2005;156:141
  22. Redmond EM, Cahill PA, Hirsch M, et al. Effect of pulse pressure on vascular smooth muscle cell migration: The role of urokinase and matrix metalloproteinase. Thromb Haemost. 1999;81:293
  23. Proia RR, Nelson PR, Mulligan-Kehoe MJ, et al. The effect of endothelial cell overexpression of plasminogen activator inhibitor-1 on smooth muscle cell migration. J Vasc Surg. 2002;36:164
  24. Sebolt-Leopold JS, Herrera R. Targeting the mitogen-activated protein kinase cascade to treat cancer. Nat Rev Cancer. 2004;4:937
  25. ayalil PK, Katiyar SK. Treatment of epigallocatechin-3-gallate inhibits matrix metalloproteinases-2 and -9 via inhibition of activation of mitogen-activated protein kinases, c-jun and NF-κB in human prostate carcinoma DU-145 cells. Prostate. 2004;59:33
  26. Nelson AR, Fingleton B, Rothenberg ML, et al. Matrix metalloproteinases: Biologic activity and clinical implications. J Clin Oncol. 2000;18:1135

PII: S0022-4804(09)00058-4

doi: 10.1016/j.jss.2009.02.015

Journal of Surgical Research
Volume 157, Issue 1 , Pages e31-e37 , November 2009